Cover Image

Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice

The anti-diabetic and anti-obesity effects of the allosteric protein tyrosine phosphatase 1B (PTP1B) inhibitor 4-(biphenyl-4-ylmethylsulfanylmethyl)-N-(hexane-1-sulfonyl)benzoylamide (KY-226) were pharmacologically evaluated. KY-226 inhibited human PTP1B activity (IC50 = 0.28 μM), but did not exhibi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuma Ito (Author), Masaki Fukui (Author), Mamoru Kanda (Author), Ko Morishita (Author), Yoshimichi Shoji (Author), Tatsuya Kitao (Author), Eiichi Hinoi (Author), Hiroaki Shirahase (Author)
Format: Book
Published: Elsevier, 2018-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items